Bafna Pharmaceuticals Ltd Quarterly Results
Q2 FY19-20 Results Summary
Revenue
The revenue stands at ₹11.57 crore, reflecting a quarter-on-quarter *(QoQ) increase of 68.91 per cent from ₹6.85 crore. This corresponds to a year-on-year *(YoY) decline of 0.00 per cent.
Operating Profit
Operating Profit stands at ₹-0.37 crore, reflecting a quarter-on-quarter *(QoQ) increase of 87.11 per cent from ₹-2.87 crore. This corresponds to a year-on-year *(YoY) decline of 0.00 per cent.
PBDT
PBDT stands at ₹0.17 crore, reflecting a quarter-on-quarter *(QoQ) increase of 106.32 per cent from ₹-2.69 crore. This corresponds to a year-on-year *(YoY) decline of 0.00 per cent.
Profit Before Tax
Profit Before Tax stands at ₹-0.55 crore, reflecting a quarter-on-quarter *(QoQ) increase of 85.18 per cent from ₹-3.71 crore. This corresponds to a year-on-year *(YoY) decline of 0.00 per cent.
Net Profit
Net Profit stands at ₹-0.59 crore, reflecting a quarter-on-quarter *(QoQ) increase of 72.30 per cent from ₹-2.13 crore. This represents a 0.00 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Bafna Pharmaceuticals Ltd Earnings
- YOY
- QOQ
Bafna Pharmaceuticals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Bafna Pharmaceuticals Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Bafna Pharmaceuticals Ltd Financial Reports
Bafna Pharmaceuticals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Bafna Pharma. | 1.46% | 7.64% | 19.00% | 95.47% | 119.78% | 200.76% |
| Anuh Pharma | 0.32% | -1.82% | -2.75% | -0.56% | 10.07% | -15.41% |
| Kilitch Drugs | 0.69% | 3.43% | -3.39% | 21.40% | 17.18% | -14.35% |
| Amanta Healthcar | 1.82% | 4.93% | 3.38% | 19.74% | 64.87% | 19.45% |
| Zim Laboratories | -1.04% | -3.23% | -7.55% | 21.12% | 51.15% | 31.87% |
| Aptus Pharma | 4.66% | 12.59% | 20.56% | 72.61% | 163.80% | 731.03% |
| Jenburkt Pharma | 0.64% | -0.06% | -4.28% | 3.33% | 4.11% | -14.68% |
Company Info
Company Information
E D & Wholetime Director : Shanmugam Hemalatha
ED / WTD : Vinayak Dinesh Dendukuri
Non-Exec & Non-Independent Dir : Upendar Mekala Reddy
Chairman & Independent Directo : Ravichandran Chitra
Company Sec. & Compli. Officer : A Mohanachandran
Non Executive Director : Akilapriya Chandrashekar Raju
Independent Non Exe. Director : Palamadai Krishnan Sundaresan